Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?

@article{Ishani2004CardiacMA,
  title={Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?},
  author={Areef Ishani and Charles A. Herzog and Allan J. Collins and Robert N. Foley},
  journal={Kidney international},
  year={2004},
  volume={65 3},
  pages={
          1017-25
        }
}
BACKGROUND There are no large randomized, controlled trials evaluating the efficacy of common cardioprotective medications on cardiovascular outcomes in the dialysis population. We aimed to determine the association between cardioprotective medications and a composite end point of cardiovascular events or death in an incident dialysis cohort. METHODS Medicare claims data were utilized to determine outcomes in participants of the Dialysis Morbidity and Mortality Wave 2 cohort. Information was… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

Medication among patients with type 1 diabetes and predialytic renal disease.

VIEW 7 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months

VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis